Estimated average glucose (eAG) : fit for purpose?KILPATRICK, E. S.Diabetic medicine. 2008, Vol 25, Num 8, pp 899-901, issn 0742-3071, 3 p.Article

Glycated haemoglobin in the year 2000KILPATRICK, E. S.Journal of clinical pathology. 2000, Vol 53, Num 5, pp 335-339, issn 0021-9746Article

The rise and fall of HbA_1c as a risk marker for diabetes complicationsKILPATRICK, E. S.Diabetologia (Berlin). 2012, Vol 55, Num 8, pp 2089-2091, issn 0012-186X, 3 p.Article

Problems in the assessment of glycaemic control in diabetes mellitusKILPATRICK, E. S.Diabetic medicine. 1997, Vol 14, Num 10, pp 819-831, issn 0742-3071Article

Haemoglobin A_1c in the diagnosis and monitoring of diabetes mellitusKILPATRICK, E. S.Journal of clinical pathology. 2008, Vol 61, Num 9, pp 977-982, issn 0021-9746, 6 p.Article

Haemochromatosis case detection by genetic testing : a new eraKILPATRICK, E. S; JAGGER, C.Annals of clinical biochemistry. 1998, Vol 35, pp 674-677, issn 0004-5632, 5Article

Intra-operative blood glucose measurements : the effect of haematocrit on glucose test stripsSMITH, E. A; KILPATRICK, E. S.Anaesthesia. 1994, Vol 49, Num 2, pp 129-132, issn 0003-2409Article

Pseudohyperkalaemia, pseudohyponatraemia and pseudohypoglycaemia in a patient with hereditary stomatocytosisKILPATRICK, E. S; BURTON, I. D.Annals of clinical biochemistry. 1997, Vol 34, pp 561-563, issn 0004-5632, 5Article

Concentration-effect and concentration-toxicity relations with lamotrigine : A prospective studyKILPATRICK, E. S; FORREST, G; BRODIE, M. J et al.Epilepsia (Copenhagen). 1996, Vol 37, Num 6, pp 534-538, issn 0013-9580Article

The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetesKILPATRICK, E. S; DOMINICZAK, M. H; SMALL, M et al.QJM (Oxford. 1994. Print). 1996, Vol 89, Num 4, pp 307-312, issn 1460-2725Article

Variability of lipids in patients with Type 2 diabetes taking statin treatment : implications for target settingSATHYAPALAN, T; ATKIN, S. L; KILPATRICK, E. S et al.Diabetic medicine. 2008, Vol 25, Num 8, pp 909-915, issn 0742-3071, 7 p.Article

Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight changeGONZALEZ, S; KILPATRICK, E. S; ATKIN, S. L et al.Diabetic medicine. 2005, Vol 22, Num 3, pp 344-345, issn 0742-3071, 2 p.Article

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndromeJAYAGOPAL, V; KILPATRICK, E. S; HOLDING, S et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 2, pp 729-733, issn 0021-972X, 5 p.Article

Biological variation of glycated hemoblobin : Implications for diabetes screening and monitoringKILPATRICK, E. S; MAYLOR, P. W; KEEVIL, B. G et al.Diabetes care. 1998, Vol 21, Num 2, pp 261-264, issn 0149-5992Article

Biological variation of cystatin C : implications for the assessment of glomerular filtration rateKEEVIL, B. G; KILPATRICK, E. S; NICHOLS, S. P et al.Clinical chemistry (Baltimore, Md.). 1998, Vol 44, Num 7, pp 1535-1539, issn 0009-9147Article

Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurementsKILPATRICK, E. S; SMALL, M; RUMLEY, A et al.Clinical chemistry (Baltimore, Md.). 1993, Vol 39, Num 5, pp 833-835, issn 0009-9147Article

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatmentKONYA, J; NG, J. M; COX, H et al.Diabetic medicine. 2013, Vol 30, Num 10, pp 1250-1254, issn 0742-3071, 5 p.Article

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndromeCHO, L. W; KILPATRICK, E. S; KEEVIL, B. G et al.Clinical endocrinology (Oxford. Print). 2009, Vol 70, Num 2, pp 233-237, issn 0300-0664, 5 p.Article

Are European standard deviation targets for haemoglobin A_1c too strict?KILPATRICK, E. S; KILPATRICK, W. S; DOMINICZAK, M. H et al.Diabetic medicine. 1998, Vol 15, Num 11, pp 920-923, issn 0742-3071Article

Apolipoprotein E and epilepsyKILPATRICK, E. S; JAGGER, C. E; SPOONER, R. J et al.Annals of clinical biochemistry. 1996, Vol 33, pp 146-147, issn 0004-5632, 2Article

Low-density lipoprotein particle size in type 2 diabetic patients and age matched controlsSTEWART, J. M; KILPATRICK, E. S; CATHCART, S et al.Annals of clinical biochemistry. 1994, Vol 31, pp 153-159, issn 0004-5632, 2Article

Biological variation of cardiovascular risk factors in patients with diabetesDAWSON, A. J; SATHYAPALAN, T; ATKIN, S. L et al.Diabetic medicine. 2013, Vol 30, Num 10, pp 1172-1180, issn 0742-3071, 9 p.Article

High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trialMELLOR, D. D; MADDEN, L. A; SMITH, K. A et al.Diabetic medicine. 2013, Vol 30, Num 4, pp 478-483, issn 0742-3071, 6 p.Article

The effect of extensive flooding in Hull on the glycaemic control of patients with diabetesNG, J; ATKIN, S. L; RIGBY, A. S et al.Diabetic medicine. 2011, Vol 28, Num 5, pp 519-524, issn 0742-3071, 6 p.Article

Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome : implications for identifying hyperandrogenaemiaCHO, L. W; KILPATRICK, E. S; JAYAGOPAL, V et al.Clinical endocrinology (Oxford. Print). 2008, Vol 68, Num 3, pp 390-394, issn 0300-0664, 5 p.Article